N-Cyclohexylmethylone

N-Cyclohexylmethylone
Clinical data
Other names	Cybutylone
Legal status
Legal status	DE: Anlage II (Authorized trade only, not prescriptible); UK: Class B; US: Unscheduled, schedule I in Virginia;
Identifiers
	IUPAC name 1-(Benzo[d][1,3]dioxol-5-yl)-2-(cyclohexylamino)propan-1-one;
PubChem CID	164946391;
ChemSpider	128918008;
UNII	AB5UNF3WUF;
CompTox Dashboard (EPA)	DTXSID601344946 ;
Chemical and physical data
Formula	C16H21NO3
Molar mass	275.348 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C(=O)C1=CC2=C(C=C1)OCO2)NC3CCCCC3;
	InChI InChI=1S/C16H21NO3/c1-11(17-13-5-3-2-4-6-13)16(18)12-7-8-14-15(9-12)20-10-19-14/h7-9,11,13,17H,2-6,10H2,1H3; Key:WZDQUORQDHVTKD-UHFFFAOYSA-N;

N-Cyclohexylmethylone (cyputylone) is a substituted cathinone derivative with stimulant effects which has been sold as a designer drug. It was first identified in the United States in 2022.^[2]^[3]